Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biobohemia is a biotechnology company focused on developing a proprietary platform for the high-yield production of recombinant proteins and vaccines. The company utilizes transgenic animal systems to produce complex therapeutic proteins in milk, aiming to significantly reduce manufacturing costs and improve scalability compared to traditional bioreactor-based methods. Biobohemia's internal pipeline includes biobetter versions of cytokines and other immunotherapies targeting oncology and infectious diseases. By leveraging its unique expression system, the company seeks to provide more affordable access to life-saving biologics. Biobohemia is headquartered in Jupiter, Florida, and continues to advance its lead candidates through preclinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biobohemia.